300 related articles for article (PubMed ID: 27897972)
1. Mechanism of allosteric regulation of β
Manna M; Niemelä M; Tynkkynen J; Javanainen M; Kulig W; Müller DJ; Rog T; Vattulainen I
Elife; 2016 Nov; 5():. PubMed ID: 27897972
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein-lipid interactions.
Bruzzese A; Gil C; Dalton JAR; Giraldo J
Sci Rep; 2018 Mar; 8(1):4456. PubMed ID: 29535353
[TBL] [Abstract][Full Text] [Related]
3. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
4. Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist.
Spijker P; Vaidehi N; Freddolino PL; Hilbers PA; Goddard WA
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4882-7. PubMed ID: 16551744
[TBL] [Abstract][Full Text] [Related]
5. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations.
Feng Z; Hou T; Li Y
J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225
[TBL] [Abstract][Full Text] [Related]
6. Influence of lipid composition on the structural stability of g-protein coupled receptor.
Mahmood I; Liu X; Neya S; Hoshino T
Chem Pharm Bull (Tokyo); 2013; 61(4):426-37. PubMed ID: 23546002
[TBL] [Abstract][Full Text] [Related]
7. Mapping the functional binding sites of cholesterol in β2-adrenergic receptor by long-time molecular dynamics simulations.
Cang X; Du Y; Mao Y; Wang Y; Yang H; Jiang H
J Phys Chem B; 2013 Jan; 117(4):1085-94. PubMed ID: 23298417
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of intracellular allosteric β
Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
[TBL] [Abstract][Full Text] [Related]
9. How To Minimize Artifacts in Atomistic Simulations of Membrane Proteins, Whose Crystal Structure Is Heavily Engineered: β₂-Adrenergic Receptor in the Spotlight.
Manna M; Kulig W; Javanainen M; Tynkkynen J; Hensen U; Müller DJ; Rog T; Vattulainen I
J Chem Theory Comput; 2015 Jul; 11(7):3432-45. PubMed ID: 26575777
[TBL] [Abstract][Full Text] [Related]
10. An allosteric modulator binds to a conformational hub in the β
Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P
Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378
[TBL] [Abstract][Full Text] [Related]
11. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
[TBL] [Abstract][Full Text] [Related]
12. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L
J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174
[TBL] [Abstract][Full Text] [Related]
13. Investigation of allosteric coupling in human β2-adrenergic receptor in the presence of intracellular loop 3.
Ozgur C; Doruker P; Akten ED
BMC Struct Biol; 2016 Jul; 16(1):9. PubMed ID: 27368374
[TBL] [Abstract][Full Text] [Related]
14. Insights into the role of Asp79(2.50) in β2 adrenergic receptor activation from molecular dynamics simulations.
Ranganathan A; Dror RO; Carlsson J
Biochemistry; 2014 Nov; 53(46):7283-96. PubMed ID: 25347607
[TBL] [Abstract][Full Text] [Related]
15. Structural insights and functional implications of inter-individual variability in β2-adrenergic receptor.
Tandale A; Joshi M; Sengupta D
Sci Rep; 2016 Apr; 6():24379. PubMed ID: 27075228
[TBL] [Abstract][Full Text] [Related]
16. Small-Molecule Positive Allosteric Modulators of the
Ahn S; Pani B; Kahsai AW; Olsen EK; Husemoen G; Vestergaard M; Jin L; Zhao S; Wingler LM; Rambarat PK; Simhal RK; Xu TT; Sun LD; Shim PJ; Staus DP; Huang LY; Franch T; Chen X; Lefkowitz RJ
Mol Pharmacol; 2018 Aug; 94(2):850-861. PubMed ID: 29769246
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol modulates the dimer interface of the β₂-adrenergic receptor via cholesterol occupancy sites.
Prasanna X; Chattopadhyay A; Sengupta D
Biophys J; 2014 Mar; 106(6):1290-300. PubMed ID: 24655504
[TBL] [Abstract][Full Text] [Related]
18. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
[TBL] [Abstract][Full Text] [Related]
19. Two classes of cholesterol binding sites for the β2AR revealed by thermostability and NMR.
Gater DL; Saurel O; Iordanov I; Liu W; Cherezov V; Milon A
Biophys J; 2014 Nov; 107(10):2305-12. PubMed ID: 25418299
[TBL] [Abstract][Full Text] [Related]
20. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]